期刊文献+

乳腺良、恶性疾病与血清雌、孕激素及雌孕激素受体的关系 被引量:10

Correlation of the serum hormone estradiol and progesterone levels and estrogen and progesterone receptors with the disease associated with breast
原文传递
导出
摘要 目的探讨血清雌二醇、孕激素及雌、孕激素受体在乳腺各组疾病中的变化及其关系。方法用化学发光免疫法测定282例乳腺疾病及100例健康女性术前血清雌二醇、孕酮,术后用免疫组化法检测130例乳腺疾病及30例正常乳腺组织雌孕激素受体,分析血清雌孕激素及受体与乳腺疾病的关系。结果血雌、孕激素含量在乳腺各组疾病中和对照组比较无显著差异性,年龄<40岁组中血雌二醇含量在乳腺增生症患者中较高,年龄≥40岁组雌二醇、孕酮激素含量在乳腺癌、乳腺纤维腺瘤患者中均较高,差异均有统计学意义。血清雌孕激素含量高及雌孕激素受体阳性率高在乳腺癌患者中较明显,乳腺各组血清雌二醇、孕酮水平较高组和同时其测定雌孕激素受体均阳性及强阳性的患者标本观察,发现乳腺癌雌二醇水平及ER、PR阳性及强阳性例数明显高于其他组。结论雌孕激素受体阳性在乳腺癌患者中较显著,乳腺各组血清雌二醇、孕酮水平较高组和同时其测定雌孕激素受体均阳性及强阳性的患者发现乳腺癌明显高于其他组,在临床上指导早期发现及治疗乳腺癌有重要参考意义。 Objective To investigate the changes and relationship of serum E 2, progestogen, estrogen receptor( ER) and progesterone receptor ( PR) in different groups of breast diseases .Methods 282 patients with breast diseases and 100 healthy women were detected serum estrogen and progestogen by the chemiluminescence immunoassay before operation ,130 patients with breast diseases and 30 normal breast tissues were detected ER and PR by the immunohistochemistry post-operation,analyse the relationship between estrogen ,progestogen,ER,PR and breast diseases .Results There were no significant deviation between disease group and control group .Group of age less than 40-year-old ER were significant higher than others , group of age more than 40-year-old shown that the estrogen and progestogen in adenofibroma and breast cancer group were higher than others .The ER and PR were significant high in each group , especially in breast cancer group .As group factors ER and PR promote the cell proliferation in normal breast tissue and breast cancer .The overexpression of ER and PR stimulate breast preneoplastic change and lead to breast cancer finally .Conclusion The serum ER and PR significant masculine in breast cancer patients .There are important reference meaning in the treatment guidance of breast cancer ,can rivalry ER and PR or neutralized overdose estrogen and progestogen .
出处 《中华临床医师杂志(电子版)》 CAS 2013年第12期67-70,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 受体 雌激素 孕激素类 雌二醇 孕酮 乳腺疾病 Receptors,estrogen Progestins Estradiol Progesterone Breast diseases
  • 相关文献

参考文献9

  • 1黄婉文,杨延斌,陶世明,杨海燕.乳腺纤维腺瘤中医辨证分型与性激素水平相关性研究[J].广州中医药大学学报,2011,28(3):226-228. 被引量:4
  • 2毛晓韵,陈浩,王欢,魏晶,范垂锋,姚凡,刘崇,金锋.伴和不伴癌的乳腺导管内增生性病变ERα与p53蛋白表达差异的研究[J].中华肿瘤防治杂志,2012,19(13):961-965. 被引量:1
  • 3Lawson J,Field AS,Champion S. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer inci-dence in Japan[J].{H}LANCET,1999.1787-1788.
  • 4Gobbi H,Dupont WD,Parl FF. Breast cancer rist associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units[J].{H}International Journal of Cancer,2005.857-859.
  • 5Allred DC,Mohsin SK,Fuqua SA. Histological and biological evolu-tion of human premalignant breast disease[J].{H}Endocrine Related Cancer,2001.47-61.
  • 6Allred DC,O′Connell P,Fuqua SA. Immohistochemical studies of early breast cancer evolution[J].{H}Breast Cancer Research and Treatment,1994.13-18.
  • 7Tanos T,Rojo LJ,Echeverria P. ER and PR signaling nods dur-ing mammary gland development[J].Braest Cancer Res,2012.210.
  • 8Caldarella A,Crocetti E,Bianchi S. Female breast cancer status according to ER,PR and HER2 expression:a population based analy-sis[J].{H}Pathology Oncology Research,2011.753-758.
  • 9Bocchinfuso WP,Jonathan K,Hewitt SC. Inductiongo fmammary gland developmentine strogen receptor 2knockout mice[J].Endocrinolo-gy,2000.2982-2994.

二级参考文献24

  • 1新世纪全国高等中医药院校规划教材编写组.中医外科学[M].北京:中国中医药出版社,2002:117.
  • 2Tavassoli FA. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification [J]. Nat Clin Pract Oncol, 2005,2(3) :116-117.
  • 3Bocangel D, Sengupta S, Mitra S, et al. p53 Mediated downregulation of the human DNA repair gene O6-methylguanine- DNA methyltransferase (MGMT) via interaction with Spl transcription factor[J]. Anticancer Res, 2009,29(10):3741-3750.
  • 4Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer[J]. J Pathol, 2011, 223(2) :116-126.
  • 5Dookeran KA, Dignam JJ, Ferrer K, et al. p53 as a marker of prognosis in African-American women with breast cancer[J]. Ann Surg Oncol, 2010,17(5) : 1398-1405.
  • 6Rohan TE, Li SQ, Hartwick R, et al. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study [J]. Cancer Epidemiol Biomarkers Prey, 2006, 15(7) : 1316-1323.
  • 7Gong G, DeVries S, Chew KL, et al. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization [J]. Clin Cancer Res, 2001,7(8): 2410-2414.
  • 8Travis RC, Key TJ. Oestrogen exposure and breast cancer risk [J]. Breast Cancer Res, 2003,5 (5) : 239-247.
  • 9Duss S, Andre S, Nicoulaz AL, et al. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells [J]. Breast Cancer Res, 2007, 9(3) :R38.
  • 10Polyak K. Breast cancer: origins and evolution [J]. J Clin Invest, 2007,117(11) :3155-3163.

共引文献3

同被引文献80

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部